Affimed N.V. (NASDAQ: AFMD) is -3.68% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $1.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AFMD stock was last observed hovering at around $0.59 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.60, the stock is 7.65% and 8.07% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.22 million and changing 2.03% at the moment leaves the stock 8.61% off its SMA200. AFMD registered -33.79% loss for a year compared to 6-month loss of 11.90%. The firm has a 50-day simple moving average (SMA 50) of $0.52 and a 200-day simple moving average (SMA200) of -$0.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 12.73% gain in the last 1 month and extending the period to 3 months gives it a 14.89%, and is 12.95% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.55% over the week and 8.05% over the month.
Affimed N.V. (AFMD) has around 228 employees, a market worth around $89.90M and $19.87M in sales. Profit margin for the company is -638.78%. Distance from 52-week low is 169.35% and -45.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-131.79%).
Affimed N.V. quarterly earnings per share for the current quarter are estimated at -$0.17 with sales reaching $1.7M over the same period.The EPS is expected to shrink by -21.83% this year, but quarterly earnings will post -77.00% year-over-year. Quarterly sales are estimated to shrink -85.90% in year-over-year returns.
79 institutions hold shares in Affimed N.V. (AFMD), with institutional investors hold 38.49% of the company’s shares. The shares outstanding are 149.34M, and float is at 129.76M with Short Float at 1.18%. Institutions hold 36.77% of the Float.
The top institutional shareholder in the company is 683 Capital Management LLC with over 9.0 million shares valued at $5.38 million. The investor’s holdings represent 6.03% of the AFMD Shares outstanding. As of Jun 29, 2023, the second largest holder is Baker Brothers Advisors, LLC with 6.6 million shares valued at $3.95 million to account for 4.42% of the shares outstanding. The other top investors are NEA Management Company, LLC which holds 4.43 million shares representing 2.96% and valued at over $2.65 million, while Point72 Asset Management, L.P. holds 2.84% of the shares totaling 4.24 million with a market value of $2.54 million.
Affimed N.V. (AFMD): Who are the competitors?
One of the company’s main competitors (and peers) include Acorda Therapeutics Inc. (ACOR) that is trading -25.27% down over the past 12 months.
